Glucomannan minimizes the postprandial insulin surge: a potential adjuvant for hepatothermic therapy
- 1 June 2002
- journal article
- Published by Elsevier BV in Medical Hypotheses
- Vol. 58 (6), 487-490
- https://doi.org/10.1054/mehy.2001.1457
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Pyruvate and hydroxycitrate/carnitine may synergize to promote reverse electron transport in hepatocyte mitochondria, effectively ‘uncoupling’ the oxidation of fatty acidsMedical Hypotheses, 1999
- Degradation of Konjac Glucomannan by Enzymes in Human Feces and Formation of Short-Chain Fatty Acids by Intestinal Anaerobic Bacteria.Journal of Nutritional Science and Vitaminology, 1998
- Insulin exposure controls the rate of mammalian agingMechanisms of Ageing and Development, 1996
- Disproportionate ileal digestion on canine food consumptionDigestive Diseases and Sciences, 1994
- Regulation of hepatic 7 alpha-hydroxylase expression by dietary psyllium in the hamster.JCI Insight, 1994
- Glucomannan prevents postprandial hypoglycaemia in patients with previous gastric surgery.Gut, 1988
- Effect of Konjac mannan on 1,2-dimethylhydrazine-induced intestinal carcinogenesis in Fischer 344 ratsCancer Letters, 1983
- Effect of Dietary Fiber, Glucomannan, on Absorption of Sulfonylurea in ManHormone and Metabolic Research, 1983
- Effect of Konjac mannan on spontaneous liver tumorigenesis and fecal flora inCancer Letters, 1982
- TREATMENT OF DIABETES WITH GLUCOMANNAN (KONJAC MANNAN)The Lancet, 1979